St. Jude Medical Financial Statements
St. Jude Medical Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
St. Jude Medical Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 4,363.3 | 3,779.3 | 3,302.4 |
| Gross Profit ($ mil.) | 3,192.7 | 2,737.7 | 2,388.9 |
| Operating Income ($ mil.) | 653.3 | 782.5 | 754.5 |
| Total Net Income ($ mil.) | 384.3 | 559.0 | 548.3 |
| Diluted EPS (Net Income) | 1.10 | 1.59 | 1.47 |
St. Jude Medical Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,159.6 | 1,184.4 | 1,184.4 |
| Gross Profit ($ mil.) | 853.9 | 878.9 | 878.9 |
| Operating Income ($ mil.) | -- | 305.3 | 305.3 |
| Total Net Income ($ mil.) | 166.9 | 219.4 | 219.4 |
| Diluted EPS (Net Income) | 0.48 | 0.63 | 0.63 |
St. Jude Medical Stock Quote & Chart
| 11/06/09 16:01:55 EST •
NYSE •
34.79
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
St. Jude Medical Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 2.68 | 2.58 | 7.00 |
| Price/Earnings Ratio | 27.93 | 67.57 | 25.45 |
| Price/Book Ratio | 3.38 | 2.97 | 6.74 |
| Price/Cash Flow Ratio | 13.18 | 14.18 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed St. Jude Medical Financial Ratios
St. Jude Medical Competitive Intelligence
| Boston Scientific | Edwards Lifesciences | Medtronic | |
|---|---|---|---|
| Annual Sales ($ mil.) | 8,050.0 | 1,237.7 | 14,599.0 |
| Employees | 24,800 | 6,200 | 41,000 |
| Market Cap ($ mil.) | 12,135.4 | 4,498.9 | 42,523.4 |
Competitive Landscape



